Arachidonic acid directly mediates the rapid effects of 24,25-dihydroxyvitamin D-3 via protein kinase C and indirectly through prostaglandin production in resting zone chondrocytes
Z. Schwartz et al., Arachidonic acid directly mediates the rapid effects of 24,25-dihydroxyvitamin D-3 via protein kinase C and indirectly through prostaglandin production in resting zone chondrocytes, ENDOCRINOL, 140(7), 1999, pp. 2991-3002
Prior studies have shown that 24,25-dihydroxyvitamin D-3 [24,25(OH)(2)D-3]
plays a major role in resting zone chondrocyte differentiation and that thi
s vitamin D metabolite regulates both phospholipase A, and protein kinase C
(PKC) specific activities. Arachidonic acid is the product of phospholipas
e A, action and has been shown in other systems to affect a variety of cell
ular functions, including PKC activity. The aim of the present study was to
examine the interrelationship between arachidonic acid and 24,25-(OH)(2)D-
3 on markers of proliferation, differentiation, and matrix production in re
sting zone chondrocytes and to characterize the mechanisms by which arachid
onic acid regulates PKC, which was shown previously to mediate the rapid ef
fects of 24,25-(OH)(2)D-3 and arachidonic acid on these cells. Confluent, f
ourth passage resting zone cells from rat costochondral cartilage were used
to evaluate these mechanisms. The addition of arachidonic acid to resting
zone cultures stimulated [H-3]thymidine incorporation and inhibited the act
ivity of alkaline phosphatase and PKC, but had no effect on proteoglycan su
lfation. In contrast, 24,25(OH)(2)D-3 inhibited [H-3]thymidine incorporatio
n and stimulated alkaline phosphatase, proteoglycan sulfation, and PKC acti
vity. In cultures treated with both agents, the effects of 24,25-(OH)(2)D-3
were reversed by arachidonic acid. The PKC isoform affected by arachidonic
acid was PKC alpha; cytosolic levels were decreased, but membrane levels w
ere unaffected, indicating that translocation did not occur. Arachidonic ac
id had a direct effect on PKC in isolated plasma membranes and matrix vesic
les, indicating a nongenomic mechanism. Plasma membrane PKCa was inhibited,
and matrix vesicle PKC zeta was stimulated; these effects were blocked by
24,25-(OH)(2)D-3. Studies using cyclooxygenase and lipoxygenase inhibitors
indicate that the effects of arachidonic acid are due in part to PG product
ion, but not to leukotriene; production. This is supported by the fact that
H8-dependent inhibition of protein kinase A, which mediates the effects of
PGE,, had no effect on the direct action of arachidonic acid but did media
te the role of arachidonic acid in the cell response to 24,25(OH)(2)D-3. Di
acylglycerol does not appear to be involved, indicating that phospholipase
C and/or D do not play a role, gamma-Linolenic acid, an unsaturated precurs
or of arachidonic acid, elicited a similar response in matrix vesicles but
not plasma membranes, whereas palmitic acid, a saturated fatty acid, had no
effect. These data suggest that arachidonic acid may act as a negative reg
ulator of 24,25-(OH)(2)D-3 action in resting zone chondrocytes.